A severity rating scale for body dysmorphic disorder: Development, reliability, and validity of a modified version of the yale-brown obsessive compulsive scale

Psychopharmacology Bulletin

Volumn 33, Issue 1, 1997, Pages 17-22

  Phillips, Katharine A ^a,d   Hollander, Eric ^b   Rasmussen, Steven A ^a   Aronowitz, Bonnie R ^b   DeCaria, Concetta ^b   Goodman, Wayne K ^c  

^a BROWN UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^d BUTLER HOSPITAL   (United States)

Author keywords

assessment; body dysmorphic disorder; obsessive compulsive disorder; somatoform disorders; treatment

Indexed keywords

FLUVOXAMINE;

ADULT; ARTICLE; BODY DYSMORPHIC DISORDER; CLINICAL TRIAL; DISEASE SEVERITY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVER VARIATION; OBSESSION; OUTCOMES RESEARCH; PHOBIA; PRIORITY JOURNAL; PSYCHOMETRY; RELIABILITY;

EID: 0030935539     PISSN: 00485764     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders, 4th ed. Washington, DC: The Association, 1994.
2. Beck, AT; Ward, DH; Mendelson, M; Mock, J; and Erbaugh, JK. An inventory for measuring depression. Arch. Gen. Psychiatry 4:561-571, 1961.
3. The Clomipramine Collaborative Study Group. Clomipramine in the treatment of patients with obsessive compulsive disorder. Arch. Gen. Psychiatry 48:730-738, 1991.
4. Goodman, WK; Price, LH; Rasmussen, SA; Mazure, C; Fleischmann, RL; Hill, CL; Heninger, GR; and Charney, DS. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part I. Development, use, and reliability. Arch. Gen. Psychiatry 46:1006-1012, 1989a.
5. Goodman, WK; Price, LH; Rasmussen, SA; Mazure, C; Delgado, P; Heninger, GR; and Charney, DS. The Yale-Brown Obsessive Compulsive Scale (Y-BOCS): Part II. Validity. Arch. Gen. Psychiatry 46:1012-1016, 1989b.
6. Hollander, E; Cohen, L; Simeon, D; Rosen, J; DeCaria, C; and Stein, DJ. Fluvoxamine treatment of body dysmorphic disorder (letter). J. Clin. Psychopharmacol. 14:75-77, 1994.
7. Hollander, E; Liebowitz, MR; Winchel, R; Klumker, A; and Klein, DF. Treatment of body-dysmorphic disorder with serotonin reuptake blockers. Am. J. Psychiatry 146:768-770, 1989.
8. Hollander, E, and Phillips, KA. Body image and experience disorders: Body dysmorphic and depersonalization disorders. In: Hollander, E, ed. Obsessive Compulsive-Related Disorders. Washington, DC: American Psychiatric Press Inc, 1993.
9. Koran, LM; McElroy, SL; Davidson, JRT; Rasmussen, SA; Hollander, E; and Jenike, MA. Fluvoxamine versus clomipramine for obsessive-compulsive disorder: A double-blind comparison. J. Clin. Psychopharmacol. 16:121-129, 1996.
10. Mazure, CM; Halmi, KA; Sunday, SR; Romano, SJ; and Einhorn, AM. The Yale-Brown-Cornell Eating Disorder Scale: Development, use, reliability and validity. J. Psychiatry Res. 28:425-445, 1994.
11. Overall, JE, and Gorham, DR. Introduction - The Brief Psychiatric Rating Scale (BPRS): Recent developments in ascertainment and scaling. Psychopharmacol. Bull. 24:97-99, 1988.
12. Phillips, KA. An open study of buspirone augmentation of serotonin-reuptake inhibitors in body dysmorphic disorder. Psychopharmacol. Bull. 32:175-180, 1996.
13. Phillips, KA; Atala, KD; and Pope, HG. Diagnostic instruments for body dysmorphic disorder. New Research Program and Abstracts. American Psychiatric Association 148th Annual Meeting. Miami: American Psychiatric Association, 1995a. p. 157.
14. Phillips, KA; McElroy, SL; Hudson, JI; and Pope, HG, Jr. Body dysmorphic disorder: An obsessive compulsive spectrum disorder, a form of affective spectrum disorder, or both? J. Clin. Psychiatry 56(S):41-51, 1995b.
15. Phillips, KA; McElroy, SL; Keck, PE, Jr, Pope, HG, Jr; and Hudson, JI. Body dysmorphic disorder 30 cases of imagined ugliness. Am. J. Psychiatry 150:302-308, 1993.
16. Phillips, KA; McElroy, SL; Keck, PE Jr; Pope, HG Jr; and Hudson, JI. A comparison of delusional and nondelusional body dysmorphic disorder in 100 cases. Psychopharmacol. Bull. 30:179-186, 1994.
17. Phillips, KA; Nierenberg, AA; Brendel, G; and Fava, M. Prevalence and clinical features of body dysmorphic disorder in atypical major depression. J. Nerv. Ment. Dis. 184:125-129, 1996.
18. Simeon, D; Hollander, E; Stein, DJ; Cohen, L; and Aronowitz, B. Body dysmorphic disorder in the DSM-IV Field Trial for obsessive compulsive disorder. Am. J. Psychiatry 152:1207-1209, 1995.